150 related articles for article (PubMed ID: 36858557)
1. [Utilization of Human iPS Cells for Evaluation of Drug Disposition and Mucosal Damages in the Small Intestine].
Iwao T
Yakugaku Zasshi; 2023; 143(3):243-247. PubMed ID: 36858557
[TBL] [Abstract][Full Text] [Related]
2. Generation of Budding-Like Intestinal Organoids from Human Induced Pluripotent Stem Cells.
Onozato D; Ogawa I; Kida Y; Mizuno S; Hashita T; Iwao T; Matsunaga T
J Pharm Sci; 2021 Jul; 110(7):2637-2650. PubMed ID: 33794275
[TBL] [Abstract][Full Text] [Related]
3. [Development of an In Vitro System for Evaluating Intestinal Drug Disposition Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells].
Iwao T
Yakugaku Zasshi; 2018; 138(10):1241-1247. PubMed ID: 30270266
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells.
Kabeya T; Mima S; Imakura Y; Miyashita T; Ogura I; Yamada T; Yasujima T; Yuasa H; Iwao T; Matsunaga T
Drug Metab Pharmacokinet; 2020 Aug; 35(4):374-382. PubMed ID: 32651148
[TBL] [Abstract][Full Text] [Related]
5. Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research.
Inui T; Uraya Y; Yokota J; Yamashita T; Kawai K; Okada K; Ueyama-Toba Y; Mizuguchi H
Stem Cell Res Ther; 2024 Feb; 15(1):57. PubMed ID: 38424603
[TBL] [Abstract][Full Text] [Related]
6. Generation of Human iPSC-Derived Intestinal Epithelial Cell Monolayers by CDX2 Transduction.
Takayama K; Negoro R; Yamashita T; Kawai K; Ichikawa M; Mori T; Nakatsu N; Harada K; Ito S; Yamada H; Yamaura Y; Hirata K; Ishida S; Mizuguchi H
Cell Mol Gastroenterol Hepatol; 2019; 8(3):513-526. PubMed ID: 31228606
[TBL] [Abstract][Full Text] [Related]
7. Characteristic Analysis of Intestinal Transport in Enterocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
Kodama N; Iwao T; Katano T; Ohta K; Yuasa H; Matsunaga T
Drug Metab Dispos; 2016 Oct; 44(10):0. PubMed ID: 27417181
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of carboxylesterase in human induced pluripotent stem cell-derived enterocytes.
Kabeya T; Matsumura W; Iwao T; Hosokawa M; Matsunaga T
Biochem Biophys Res Commun; 2017 Apr; 486(1):143-148. PubMed ID: 28285137
[TBL] [Abstract][Full Text] [Related]
9. Comparison of human biopsy-derived and human iPS cell-derived intestinal organoids established from a single individual.
Inui T; Yamashita T; Tomita J; Yokota J; Kishimoto W; Nakase H; Mizuguchi H
Drug Metab Pharmacokinet; 2023 Feb; 48():100482. PubMed ID: 36653202
[TBL] [Abstract][Full Text] [Related]
10. Generation of Intestinal Organoids Suitable for Pharmacokinetic Studies from Human Induced Pluripotent Stem Cells.
Onozato D; Yamashita M; Nakanishi A; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Nov; 46(11):1572-1580. PubMed ID: 29615438
[TBL] [Abstract][Full Text] [Related]
11. Application of Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids as a Model of Epithelial Damage and Fibrosis in Inflammatory Bowel Disease.
Onozato D; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
Biol Pharm Bull; 2020; 43(7):1088-1095. PubMed ID: 32612071
[TBL] [Abstract][Full Text] [Related]
12. Protective Effect of Irsogladine against Aspirin-Induced Mucosal Injury in Human Induced Pluripotent Stem Cell-Derived Small Intestine.
Kanno T; Katano T; Ogawa I; Iwao T; Matsunaga T; Kataoka H
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676718
[No Abstract] [Full Text] [Related]
13. Utility of human induced pluripotent stem cell-derived small intestinal epithelial cells for pharmacokinetic, toxicological, and immunological studies.
Imakura Y; Mima S; Yamazaki N; Inomata A; Mochizuki S; Iwao T; Matsunaga T
Biochem Biophys Res Commun; 2024 Jan; 692():149356. PubMed ID: 38071890
[TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP Signaling Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Intestinal Epithelial Cells.
Kabeya T; Qiu S; Hibino M; Nagasaki M; Kodama N; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Oct; 46(10):1411-1419. PubMed ID: 30068521
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Function and Features of Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells for Analyzing Peptide Drug Intestinal Absorption Profiles.
Itagaki M; Kamei N; Takeda-Morishita M
J Pharm Sci; 2023 Sep; 112(9):2591-2595. PubMed ID: 37230251
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Human Cell-Based Experimental Models for the Evaluation of Enteric Metabolism and Drug Interaction Potential of Drugs and Natural Products.
Li AP
Drug Metab Dispos; 2020 Oct; 48(10):980-992. PubMed ID: 32636209
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid promotes barrier functions in human iPSC-derived intestinal epithelial monolayers.
Yamada S; Kanda Y
J Pharmacol Sci; 2019 Aug; 140(4):337-344. PubMed ID: 31399314
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Evaluation of Membrane Permeability and UDP-Glucuronosyltransferase-Mediated Metabolism of Food-Derived Compounds Using Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells.
Kitaguchi T; Mizota T; Ito M; Ohno K; Kobayashi K; Ogawa I; Qiu S; Iwao T; Hanioka N; Tanaka M; Matsunaga T
Drug Metab Dispos; 2022 Jan; 50(1):17-23. PubMed ID: 34670778
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 expression, induction and activity in human induced pluripotent stem cell-derived intestinal organoids and comparison with primary human intestinal epithelial cells and Caco-2 cells.
Janssen AWF; Duivenvoorde LPM; Rijkers D; Nijssen R; Peijnenburg AACM; van der Zande M; Louisse J
Arch Toxicol; 2021 Mar; 95(3):907-922. PubMed ID: 33263786
[TBL] [Abstract][Full Text] [Related]
20. Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells.
Negoro R; Takayama K; Nagamoto Y; Sakurai F; Tachibana M; Mizuguchi H
Biochem Biophys Res Commun; 2016 Apr; 472(4):631-6. PubMed ID: 26966071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
